Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
New research indicates proportion of young women who have never been screened for cervical cancer more than doubled since 2005
Developed by a British firm, the test will be available as a $29 add-on to pricier genetic profiling assays
Clinical laboratories may soon be able to use a simplified LDL cholesterol calculation
Arun Wiita from USCF details his lab’s work using mass spectrometry
The CIZ1B biomarker blood-based assay has 95% sensitivity for detecting earliest stage of the cancer
Research shows that large language models lack reasoning skills required for clinical decision-making
Life sciences and clinical laboratories are accelerating zero-carbon goals, says My Green Lab CEO
The startup is trying to close the care gap between female and male patients
New evidence-based recommendations encourage pathology laboratories to formalize review processes
The momentum for targeted therapies has downstream implications for clinical laboratories
Roche acquires a workflow rather than a company, says AI industry observer
Labcorp’s new genotyping test can identify gene variants that may make standard oncologic treatment deadly for some
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
